December 19, 2023
Japanese beverage manufacturer DyDo Group Holdings said on December 18 that its subsidiary DyDo Pharma made a Japan submission for a Lambert-Eaton myasthenic syndrome (LEMS) treatment. This marks the first new drug application filed by DyDo Pharma. The application was...read more